Immuron Limited
IMRN
$0.71
-$0.04-5.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.88% | 25.77% | 47.00% | 62.05% | 82.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.88% | 25.77% | 47.00% | 62.05% | 82.60% |
| Cost of Revenue | 24.90% | 38.18% | 59.17% | 105.96% | 215.64% |
| Gross Profit | 5.61% | 19.86% | 41.29% | 46.27% | 51.74% |
| SG&A Expenses | -1.14% | 7.22% | 18.82% | 28.53% | 39.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 53.94% | 57.26% | 59.18% | 40.06% | 16.91% |
| Total Operating Expenses | -2.34% | 8.40% | 23.38% | 43.34% | 71.40% |
| Operating Income | 18.56% | 9.78% | -1.19% | -25.29% | -60.19% |
| Income Before Tax | 38.38% | 32.77% | 25.96% | -15.32% | -88.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 38.38% | 32.77% | 25.96% | -15.32% | -88.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.38% | 32.77% | 25.96% | -15.32% | -88.13% |
| EBIT | 18.56% | 9.78% | -1.19% | -25.29% | -60.19% |
| EBITDA | 18.74% | 10.03% | -0.83% | -25.06% | -59.91% |
| EPS Basic | 43.13% | 35.92% | 27.50% | -13.38% | -85.09% |
| Normalized Basic EPS | 39.84% | 31.67% | 21.55% | -20.22% | -98.39% |
| EPS Diluted | 43.13% | 35.92% | 27.50% | -13.38% | -85.09% |
| Normalized Diluted EPS | 39.84% | 31.67% | 21.55% | -20.22% | -98.39% |
| Average Basic Shares Outstanding | 11.16% | 6.26% | 1.35% | 0.77% | 0.19% |
| Average Diluted Shares Outstanding | 11.16% | 6.26% | 1.35% | 0.77% | 0.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |